儿童患者移植后淋巴增殖性疾病的预测因素
本研究回顾性查询一家四级儿童医院23年(2000—2023年)的电子病历,纳入114例接受扁桃体切除术和/或腺样体切除术的实体器官移植患儿,其中32例(28.1%)最终病理为移植后淋巴增殖性疾病(PTLD)。PTLD患儿更常见扁桃体较小、咽痛、发热、扁桃体渗出物,较少出现睡眠呼吸障碍;EBV PCR拷贝数升高与PTLD风险增加相关(p<0.003)。
要点
- 114例中32例(28.1%)病理为PTLD,扁桃体肥大和睡眠呼吸障碍不一定提示PTLD。
- PTLD患儿更常见扁桃体较小、咽痛、发热、扁桃体渗出物,较少出现睡眠呼吸障碍。
- EBV PCR拷贝数升高与PTLD风险增加相关(p<0.003)。
核心结论
- 扁桃体肥大和睡眠呼吸障碍不一定提示PTLD的存在。
- 对腺扁桃体PTLD的怀疑应基于症状、临床检查、EBV血清学和EBV PCR阳性程度。
- 咽痛、发热、扁桃体渗出物和EBV PCR拷贝数显著升高尤其令人担忧PTLD。
研究设计与样本
- 回顾性查询一家四级儿童医院23年期间(2000—2023年)的电子病历,纳入接受扁桃体切除术和/或腺样体切除术的实体器官移植患者。
- 共114例患者符合纳入标准进行分析。
主要发现
- 114例接受扁桃体切除术和/或腺样体切除术的患者中,32例(28.1%)有PTLD。
- 移植时年龄、活检时年龄、性别、种族和移植器官类型与PTLD发生无关。
- PTLD患者更可能有较小的扁桃体、咽痛、发热和扁桃体渗出物,较少出现睡眠呼吸障碍。
- 诱导所用免疫抑制剂和维持免疫抑制药物数量与PTLD发生无关。
- EBV PCR拷贝数增加与发生PTLD风险增加相关(p<0.003)。
关键数值与推荐
- PTLD患儿更常见扁桃体较小、咽痛、发热、扁桃体渗出物,较少出现睡眠呼吸障碍。
- EBV PCR拷贝数增加与PTLD风险增加相关(p<0.003)。
- 证据等级:3。
临床怎么用
- 对腺扁桃体PTLD的怀疑应基于症状、临床检查、EBV血清学和EBV PCR阳性程度。
- 咽痛、发热、扁桃体渗出物和EBV PCR拷贝数显著升高尤其令人担忧PTLD。
- 扁桃体肥大和睡眠呼吸障碍不一定提示PTLD的存在。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Posttransplant lymphoproliferative disorder (PTLD) is a complication of pediatric solid organ transplantation. Benign adenotonsillar lymphoid hyperplasia confounds the ability to diagnose PTLD. Our aim was to identify factors that predict the presence of PTLD to inform decision-making regarding adenotonsillectomy. METHODS: The electronic medical records at a quaternary children's hospital were queried over a 23-year period (2000-2023) for solid organ transplant patients that underwent tonsillectomy and/or adenoidectomy. Demographics, clinical presentation, and EBV serologies were analyzed to determine factors associated with presence of PTLD on final pathology. RESULTS: A total of 114 patients met inclusion criteria for analysis. Thirty-two of the 114 patients (28.1%) who underwent tonsillectomy and/or adenoidectomy had PTLD. Age at transplant, age at biopsy, sex, race, and type of organ transplanted were not found to be associated with development of PTLD. Patients with PTLD were more likely to have smaller tonsils, sore throat, fever, and tonsillar exudate; they were less likely to experience sleep disordered breathing. The immunosuppression agent used for induction and the number of maintenance immunosuppressive medications were not associated with the development of PTLD. Increased Epstein-Barr Virus (EBV) PCR copy number correlated to increased risk of developing PTLD (p < 0.003). CONCLUSION: Tonsillar hypertrophy and sleep disordered breathing are not necessarily indicative of the presence of PTLD. Suspicion for adenotonsillar PTLD should be based on symptomatology, clinical exam, EBV serologies, and degree of EBV PCR positivity. Sore throat, fever, tonsillar exudates, and significant elevation in EBV PCR copy number are particularly concerning for PTLD. LEVEL OF EVIDENCE: 3 Laryngoscope, 135:2182-2189, 2025.
引用
- Campbell B, Kacin AJ, Morey J, et al. Predictors of Posttransplant Lymphoproliferative Disease in Pediatric Patients. Laryngoscope. 2025. PMID: 39887368. doi:10.1002/lary.32024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。